CRESY:NASDAQCresud S.A.C.I.F. y A. Analysis
Data as of 2026-06-22 - not real-time
$11.66
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical momentum is firmly on the upside: the stock trades above its short‑term and medium‑term moving averages, the MACD line sits above its signal line, and the RSI hovers around the midpoint, all pointing to a bullish trend. Valuation signals are equally compelling, with a price‑to‑earnings multiple far below the industry average, a dividend yield that ranks among the highest in the sector, and a discounted‑cash‑flow model indicating a sizable upside potential.
However, the balance sheet raises cautionary flags. The company carries a very high debt‑to‑equity ratio and reports negative free cash flow despite a sizable cash pile, while its beta exceeds one and recent volatility has been elevated. Geographic concentration in Argentina adds regulatory and currency exposure, which could temper the upside despite the attractive price and income profile.
However, the balance sheet raises cautionary flags. The company carries a very high debt‑to‑equity ratio and reports negative free cash flow despite a sizable cash pile, while its beta exceeds one and recent volatility has been elevated. Geographic concentration in Argentina adds regulatory and currency exposure, which could temper the upside despite the attractive price and income profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical indicators (price above SMAs, MACD bullish)
- Attractive dividend yield offering immediate income
- Valuation gap suggesting near‑term price appreciation
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Undervalued price relative to earnings and DCF
- High debt load and negative free cash flow
- Continued macro‑economic and currency headwinds in Argentina
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant upside potential from low valuation multiples
- Sustainable long‑term dividend income if cash generation improves
- Potential for balance‑sheet deleveraging and stronger cash flow over time
Key Metrics & Analysis
Financial Health
Revenue Growth5.00%
Profit Margin18.04%
P/E Ratio5.8
ROE16.04%
ROA1.90%
Debt/Equity69.06
P/B Ratio0.9
Op. Cash Flow$198.7B
Free Cash Flow$-126445125632
Industry P/E31.4
Technical Analysis
TrendBullish
RSI50.5
Support$10.64
Resistance$12.80
MA 20$11.67
MA 50$11.41
MA 200$11.27
MACDBullish
VolumeStable
Fear & Greed Index91.46
Valuation
Fair Value$13,845.64
Target Price$15.51
Upside/Downside32.98%
GradeUndervalued
TypeValue
Dividend Yield5.40%
Risk Assessment
Beta1.37
Volatility50.41%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.